Prestige Consumer Healthcare Inc. buy StockNews.com
Start price
16.12.23
/
50%
€54.50
Target price
16.12.24
-
Performance (%)
42.20%
End price
17.12.24
€77.50
Summary
This prediction ended on 17.12.24 with a price of €77.50. With a performance of 42.20% the BUY prediction by StockNews_com was a big success. StockNews_com has a follow-up prediction for Prestige Consumer Healthcare Inc. where he still thinks Prestige Consumer Healthcare Inc. is a Buy. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. | 0.405% | 0.405% | -36.410% |
| iShares Core DAX® | 2.119% | -1.935% | 22.352% |
| iShares Nasdaq 100 | 1.877% | -0.064% | 9.394% |
| iShares Nikkei 225® | 1.760% | -0.910% | 15.763% |
| iShares S&P 500 | 1.962% | 0.689% | 3.355% |
Comments by StockNews_com for this prediction
In the thread Prestige Consumer Healthcare Inc. diskutieren
Prestige Consumer Healthcare Inc. (NYSE: PBH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for PBH provided by MarketBeat
In the thread Trading Prestige Consumer Healthcare Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Current prediction by StockNews_com for Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare Inc.
Start price
Target price
Perf. (%)
€77.50
17.05.25
17.05.25
-
17.05.26
17.05.26
-35.48%
26.11.25
26.11.25
Stopped prediction by StockNews_com for Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare Inc.
Start price
Target price
Perf. (%)
€63.00
10.02.24
10.02.24
-
10.02.25
10.02.25
30.16%
11.02.25
11.02.25
Prestige Consumer Healthcare Inc.
Start price
Target price
Perf. (%)
€52.50
24.06.23
24.06.23
-
24.06.24
24.06.24
20.95%
25.06.24
25.06.24